- High efficacy treatment since the first attack - an important step in the treatment of multiple sclerosis?2023 | First Faculty of Medicine
- Ofatumumab - a new high-efficacy treatment for relapsing forms of multiple sclerosis2021 | Faculty of Medicine in Hradec Králové
- Ofatumumab - a highly effective therapy for relapsing-remitting multiple sclerosis available in the first line2022 | Faculty of Medicine in Hradec Králové
- Early high efficacy mulitple sclerosis treatment: therapeutic success despite safety barriers2023 | First Faculty of Medicine
- Ocrelizumab since the first multiple sclerosis attack - a milestone in reimbursement criteria2022 | First Faculty of Medicine